跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HER2-CAR-T
首页
药物
HER2-CAR-T
HER2-CAR-T
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
UNIVERSAL IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
EP 3250695 B1
申请人: BAYLOR COLLEGE MEDICINE
优先权: 2015
EP
US
WO
7 件公开
T-CELLS COMPRISING TWO DIFFERENT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
EP 3720882 A4
申请人: MEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT
优先权: 2017
EP
US
WO
4 件公开
COMBINED HER2 AND MESO DUAL-TARGET CAR-T VECTOR, CONSTRUCTION METHOD THEREFOR AND APPLICATION THEREOF IN CANCER
US 2024366671 A1
申请人: SHANGHAI INST OF BIOLOGICAL PRODUCTS CO LTD
优先权: 2021
CN
US
2 件公开
METHODS FOR THE DETECTION AND TREATMENT OF RESISTANT CANCERS CO-EXPRESSING ALPP AND/OR ALPG/ALPPL2
EP 4801949 A1
申请人: UNIV TEXAS
优先权: 2023
EP
WO
2 件公开
CAR molecule and CAR-T cell targeting SIA-IgG and application
CN 115873130 A
申请人: DING MENGTING
优先权: 2022
CN
2 件公开
Anti-tumor drug combination and application thereof
CN 119971030 A
申请人: NANKAI INTERNATIONAL ADVANCED RES INSTITUTE SHENZHEN FUTIAN
优先权: 2025
CN
2 件公开
抗HER2嵌合抗原受体、编码基因、重组表达载体及其构建方法和应用
CN 105949318 B
申请人: 上海优卡迪生物医药科技有限公司
优先权: 2016
CN
CAR-T cell as well as preparation method and application thereof
CN 106047817 A
申请人: SHENZHEN ISTEM REGENERATIVE MEDICINE SCI-TECH CO LTD
优先权: 2016
CN
Infection mixture and preparation method thereof
CN 106222200 A
申请人: SHENZHEN ISTEM REGENERATIVE MEDICINE SCI-TECH CO LTD
优先权: 2016
CN
CAR (chimeric antigen receptor) expression carrier and construction method thereof
CN 106191117 A
申请人: SHENZHEN ISTEM REGENERATIVE MEDICINE SCI-TECH CO LTD
优先权: 2016
CN
第 1 / 8 页
上一页
下一页
药物
反馈